Clinical · 18 June 2026

UKHSA Issues PGD Template for Flu Vaccines IIV and LAIV

The UK Health Security Agency has published a patient group direction template covering inactivated and live attenuated influenza vaccines for the seasonal flu programme.

The UK Health Security Agency (UKHSA) has published a patient group direction (PGD) template relating to influenza vaccination, according to guidance posted on the official government website.

Two Vaccine Types Covered

The PGD template addresses two distinct influenza vaccine formulations: the inactivated influenza vaccine (IIV) and the live attenuated influenza vaccine (LAIV). Both are included within the scope of the single published document.

Alignment with the Seasonal Programme

According to UKHSA, the PGD is intended for use in line with the national seasonal flu vaccination programme. The guidance is framed as a template to support healthcare practitioners involved in delivering influenza vaccines during the seasonal campaign.

No additional clinical or epidemiological data was included in the published guidance metadata.

References

  1. Guidance: Influenza vaccine (IIV and LAIV) patient group direction (PGD) UKHSA
This is news reporting and is not medical advice. For medical questions, consult a doctor.